"我们彼此保持安全":开发和实施减少危害的健康传播活动,以防止芬太尼过量服用
Catherine Cunningham1, Susan Kirtz1, Michael Mackert1,2
1Center for Health Communication, Moody College of Communication and Dell Medical School, The University of Texas at Austin, Austin, TX, USA.
Substance use & misuse
|December 17, 2025
概括
芬太尼过量死亡人数正在上升,特别是在德克萨斯州奥斯. 一个新的减少危害的运动",在奥斯,我们保持彼此安全",旨在教育使用毒品的人 (PWUD) 关于更安全的做法.
科学领域:
- 公共卫生 公共卫生
- 卫生传播健康传播
- 药物使用研究研究 药物使用研究
背景情况:
- 从2015年到2022年,芬太尼过量死亡人数在全国范围内激增,德克萨斯州特拉维斯县的死亡率最高.
- 尽管人们对芬太尼有意识,但特拉维斯县的吸毒者 (PWUD) 却表现出较低的减少危害行为.
- 当地卫生部门与PWUD合作创建了一项以减少危害为重点的健康传播活动,以应对日益增加的过量死亡.
研究的目的:
- 描述一个文化上有能力,基于证据的健康传播活动的开发和传播.
- 实施减少危害的原则,以减少与芬太尼相关的局部过量死亡.
- 讨论未来研究和公共卫生倡议的更广泛影响.
主要方法:
- 进行了环境扫描,并利用了以前的研究结果.
- 采用社区参与的方法来开发竞选活动.
- 开发和传播了一场针对德克萨斯州奥斯PWUD的大众媒体活动.
主要成果:
- 一个大众媒体活动, "在奥斯,我们保持彼此安全", 已成功开发和传播.
- 该活动的重点是向PWUD提供非污名化,基于事实的信息.
- 该方法将基于证据的策略与社区参与相结合.
结论:
- 减少危害的策略有效地支持PWUD,提供事实信息,以更安全的物质消费.
- 社区参与的,以证据为基础的健康传播活动可以通过关键的健康信息接触到边缘化受众.
- 这种运动模式可以适应针对利基人群的其他公共卫生问题.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
457
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
457
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Prescription, Nonprescription and Orphan Drugs
1.1K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
872
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
872
Levels of Health Promotion and Illness Prevention
14.1K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
14.1K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K


